Display Settings:

Format

Send to:

Choose Destination
    Gynecol Oncol. 2003 Mar;88(3):459-62.

    Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

    Source

    Division of Gynecological Oncology, Department of Obstetrics & Gynecology, University Hospitals Leuven, 3000, Leuven, Belgium. Frederic.Amant@uz.kuleuven.ac.be

    Abstract

    BACKGROUND:

    Endometrial stromal sarcomas (ESSs) exhibit varying degrees of malignancy and heterogeneity at the karyotypic level. The biological mechanisms that contribute to tumorigenesis of ESS are still largely unknown.

    CASE:

    A 33-year-old woman suffering from ESS was treated primarily surgically. Cytogenetic evaluation of the primary uterine nodule and metastatic tumor showed 46,XX,t(X;17)(p11:q23) karyotype in all metaphases analyzed. Normal endometrial cells exhibited 46,XX karyotype. Fluorescence in situ hybridization analysis confirmed the presence of the reciprocal t(X;17) translocation and allowed for the positioning of the chromosome X breakpoint distal to SSX1 gene loci.

    CONCLUSIONS:

    Our report of a previously undescribed sole cytogenetic translocation in an advanced stage of ESS might identify a cytogenetically distinct subgroup of ESS and help to reveal genes involved in ESS tumorigenesis.

    PMID:
    12648605
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk